To achieve this, the alterations in glycogenolysis, the Glu transporter type 4 (GLUT4)-5′ AMP-activated protein kinase (AMPK) signaling pathway, and insulin resistance were analyzed in the liver tissues of WT and Lep KO mice orally administered MPs for 9 weeks. The gene discussed is SLC2A4; the disease is Insulin resistance.